NCT00826644View on ClinicalTrials.gov

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

PHASE3CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Carcinoma, Small Cell
Interventions
DRUG

Belotecan

Belotecan : 0.5mg/㎡/day for Day 1 to 4, repeated every 3 weeks

DRUG

Etoposide

Etoposide 100mg/㎡/day for Day 1 to 3, repeated every 3 weeks

DRUG

Cisplatin

Cisplatin 60mg/㎡/day for Day 1, repeated every 3 weeks

Trial Locations (1)

58128

Chonnam National University Hwasun Hospital, Hwasun

Sponsors
All Listed Sponsors
collaborator

Chong Kun Dang Pharmaceutical

INDUSTRY

lead

Chonnam National University Hospital

OTHER

NCT00826644 - Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | Biotech Hunter | Biotech Hunter